Kahn RS - Search Results

1

Serotonin receptor responsivity in schizophrenia.

Kahn RS, Davidson M. Kahn RS, et al. Int Clin Psychopharmacol. 1993 Nov;8 Suppl 2:47-51. doi: 10.1097/00004850-199311002-00007. Int Clin Psychopharmacol. 1993. PMID: 7911140 Review. No abstract available.

2

Serotonin function in schizophrenia: effects of meta-chlorophenylpiperazine in schizophrenic patients and healthy subjects.

Kahn RS, Siever LJ, Gabriel S, Amin F, Stern RG, DuMont K, Apter S, Davidson M. Kahn RS, et al. Psychiatry Res. 1992 Jul;43(1):1-12. doi: 10.1016/0165-1781(92)90136-q. Psychiatry Res. 1992. PMID: 1332094 Clinical Trial.

3

Measurements of plasma homovanillic acid in schizophrenic patients.

Davidson M, Kahn RS, Stern RG, Harvey PD, Keefe R, Knott P, Apter S, Webster L, Davis KL. Davidson M, et al. Among authors: kahn rs. Clin Neuropharmacol. 1992;15 Suppl 1 Pt A:521A-522A. doi: 10.1097/00002826-199201001-00271. Clin Neuropharmacol. 1992. PMID: 1354058 No abstract available.

4

Effect of m-chlorophenylpiperazine on plasma homovanillic acid concentrations in healthy subjects.

Kahn RS, Knott P, Gabriel S, DuMont K, Mastroianni L, Davidson M. Kahn RS, et al. Biol Psychiatry. 1992 Dec 1;32(11):1055-61. doi: 10.1016/0006-3223(92)90068-b. Biol Psychiatry. 1992. PMID: 1467386 Clinical Trial.

5

Nocturnal growth hormone secretion in schizophrenic patients and healthy subjects.

Kahn RS, Davidson M, Hirschowitz J, Stern RG, Davis BM, Gabriel S, Moore C, Davis KL. Kahn RS, et al. Psychiatry Res. 1992 Feb;41(2):155-61. doi: 10.1016/0165-1781(92)90107-e. Psychiatry Res. 1992. PMID: 1574542

6

Changes in plasma homovanillic acid concentrations in schizophrenic patients following neuroleptic discontinuation.

Davidson M, Kahn RS, Powchik P, Warne P, Losonczy MF, Kaminsky R, Apter S, Jaff S, Davis KL. Davidson M, et al. Among authors: kahn rs. Arch Gen Psychiatry. 1991 Jan;48(1):73-6. doi: 10.1001/archpsyc.1991.01810250075011. Arch Gen Psychiatry. 1991. PMID: 1670618

7

Dopamine in schizophrenia: a review and reconceptualization.

Davis KL, Kahn RS, Ko G, Davidson M. Davis KL, et al. Among authors: kahn rs. Am J Psychiatry. 1991 Nov;148(11):1474-86. doi: 10.1176/ajp.148.11.1474. Am J Psychiatry. 1991. PMID: 1681750 Review.

8

Brief neuroleptic discontinuation and clinical symptoms in Kraepelinian and non-Kraepelinian chronic schizophrenic patients.

Harvey PD, Putnam KM, Davidson M, Kahn RS, Powchik P, McQueeney R, Keefe RS, Davis KL. Harvey PD, et al. Among authors: kahn rs. Psychiatry Res. 1991 Sep;38(3):285-92. doi: 10.1016/0165-1781(91)90018-k. Psychiatry Res. 1991. PMID: 1684442

9

Effects of neuroleptic treatment on symptoms of schizophrenia and plasma homovanillic acid concentrations.

Davidson M, Kahn RS, Knott P, Kaminsky R, Cooper M, DuMont K, Apter S, Davis KL. Davidson M, et al. Among authors: kahn rs. Arch Gen Psychiatry. 1991 Oct;48(10):910-3. doi: 10.1001/archpsyc.1991.01810340042005. Arch Gen Psychiatry. 1991. PMID: 1929760

10

Effects of indomethacin on plasma homovanillic acid concentration in normal subjects: a study of prostaglandin-dopamine interactions.

Kahn RS, Davidson M, Kanof P, McQueeney RT, Singh RR, Davis KL. Kahn RS, et al. Psychopharmacology (Berl). 1991;103(1):95-8. doi: 10.1007/BF02244081. Psychopharmacology (Berl). 1991. PMID: 2006246 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,144 results

Search Page

Filters